Patrick Leung, MD
Adult Reconstructive Orthopaedic Surgery · Garden City, NYNPI 1811335748
Payments from drug & device makers
What this record shows
Stryker accounts for 89.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $4,059 and has fallen 83.6% since, to $666 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NY, where the typical reported total is $11,547.
Across 74 payments — averaging $106.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$7K
- Smith+Nephew$364
- AbbVie$136
- Zimmer Biomet$116
- DJO, LLC$86
- Orthosensor Inc.$35
- plus $74 from 3 others
What the payments were for
- Travel & lodging$3,21641%
- Food & beverage$4,65459%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 59 | $7,058 |
| Smith+Nephew | 2 | $364 |
| AbbVie | 3 | $136 |
| Zimmer Biomet | 3 | $116 |
| DJO, LLC | 2 | $86 |
| Orthosensor Inc. | 2 | $35 |
| Kerecis Limited | 1 | $32 |
| Boehringer Ingelheim | 1 | $24 |
| Amgen | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$5,563
- Journey II BCS$364
- ACCOLADE$291
- Anthology$194
- T-Fix$170
- PICO 7 Single Use Negative Pressure Wound Therapy$170
- REDAPT Revision Hip System$170
- UBRELVY$108
How this compares
$7,870 in reported general payments places this provider in the 35th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.
See all adult reconstructive orthopaedic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 44 | $4,907 |
| Celecoxib | 48 | $1,955 |
| Methylprednisolone | 173 | $1,119 |
| Meloxicam | 383 | $904 |
| Ibuprofen | 30 | $214 |
| Gabapentin | 35 | $179 |
| Oxycodone Hcl | 15 | $80 |
| Cyclobenzaprine Hcl | 15 | $46 |
| Amoxicillin | 19 | $31 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Garden City
- Frank DimaioGarden City$149K
- Seth JerabekNew York$7.1M
- Jose RodriguezNew York$3.4M
- Friedrich BoettnerNew York$2.9M
- Jonathan VigdorchikNew York$2.3M
- William LongNew York$1.5M
- Peter SculcoNew York$1.5M
- Roshan ShahNew York$1.3M
- Herbert CooperNew York$1.3M
- Matthew AustinNew York$986K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.